Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Net Cash Flow: 2023-2025

Historic Net Cash Flow for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $36.2 million.

  • Camp4 Therapeutics' Net Cash Flow rose 459.19% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year increase of 251.62%. This contributed to the annual value of $25.6 million for FY2024, which is 157.53% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported Net Cash Flow of $36.2 million as of Q3 2025, which was up 452.96% from -$10.3 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Net Cash Flow peaked at $61.5 million during Q4 2024, and registered a low of -$14.7 million during Q1 2025.
  • Moreover, its 3-year median value for Net Cash Flow was -$10.8 million (2024), whereas its average is $3.1 million.
  • As far as peak fluctuations go, Camp4 Therapeutics' Net Cash Flow surged by 608.50% in 2024, and later dropped by 29.67% in 2025.
  • Camp4 Therapeutics' Net Cash Flow (Quarterly) stood at -$12.1 million in 2023, then surged by 608.50% to $61.5 million in 2024, then soared by 459.19% to $36.2 million in 2025.
  • Its last three reported values are $36.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$14.7 million during Q1 2025.